Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

644 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long-term outcome.
Kanamori H, Enaka M, Ito S, Motohashi K, Hagihara M, Oshima R, Sakai R, Fujisawa S, Tanaka M, Fujimaki K, Fujita H, Ishigatsubo Y, Maruta A. Kanamori H, et al. Among authors: hagihara m. Int J Lab Hematol. 2010 Apr;32(2):222-9. doi: 10.1111/j.1751-553X.2009.01175.x. Epub 2009 Jul 1. Int J Lab Hematol. 2010. PMID: 19573175
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.
Nakasone H, Kanda Y, Ueda T, Matsumoto K, Shimizu N, Minami J, Sakai R, Hagihara M, Yokota A, Oshima K, Tsukada Y, Tachibana T, Nakaseko C, Fujisawa S, Yano S, Fujita H, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group of Cell Therapy. Nakasone H, et al. Among authors: hagihara m. Am J Hematol. 2009 Dec;84(12):809-14. doi: 10.1002/ajh.21552. Am J Hematol. 2009. PMID: 19862826 Free article.
Cerebral venous sinus thrombosis after allogeneic stem cell transplantation.
Motohashi K, Hagihara M, Ito S, Tachibana T, Takasaki H, Tanaka M, Maruta A, Ishigatsubo Y, Kanamori H. Motohashi K, et al. Among authors: hagihara m. Int J Hematol. 2010 Jan;91(1):154-6. doi: 10.1007/s12185-009-0469-0. Epub 2010 Jan 5. Int J Hematol. 2010. PMID: 20047098 No abstract available.
[Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy].
Hagihara M, Kanamori H, Sakai M, Mori T, Nakaseko C, Aotsuka N, Uehara T, Sakura T, Yoshiba F, Kawai N, Tanaka M, Fujisawa S, Ohwada C, Wakita H, Yokota A, Kawamura T, Maruta A, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Hagihara M, et al. Rinsho Ketsueki. 2010 Jun;51(6):390-7. Rinsho Ketsueki. 2010. PMID: 20622484 Japanese.
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, Hagihara M, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: hagihara m. Int J Hematol. 2011 Mar;93(3):368-374. doi: 10.1007/s12185-011-0784-0. Epub 2011 Feb 18. Int J Hematol. 2011. PMID: 21331523
Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk.
Tachibana T, Tanaka M, Numata A, Takasaki H, Ito S, Ohshima R, Hagihara M, Yamazaki E, Tomita N, Fujimaki K, Taguchi J, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: hagihara m. Leuk Lymphoma. 2012 Mar;53(3):456-61. doi: 10.3109/10428194.2011.619607. Epub 2011 Oct 24. Leuk Lymphoma. 2012. PMID: 21883028
R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma.
Tomita N, Takasaki H, Miyashita K, Fujisawa S, Ogusa E, Matsuura S, Kishimoto K, Numata A, Fujita A, Ohshima R, Kuwabara H, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Fujimaki K, Taguchi J, Sakai R, Ishigatsubo Y. Tomita N, et al. Among authors: hagihara m. Br J Haematol. 2013 May;161(3):383-8. doi: 10.1111/bjh.12281. Epub 2013 Feb 25. Br J Haematol. 2013. PMID: 23432318 Free article.
Drug-induced liver injury after allogeneic bone marrow transplantation.
Tachibana T, Nozaki A, Enaka M, Yamamoto E, Kawasaki R, Koharazawa H, Hagihara M, Ishibashi D, Nakajima Y, Kuwabara H, Tomita N, Ishigatsubo Y, Fujisawa S. Tachibana T, et al. Among authors: hagihara m. Int J Hematol. 2013 Oct;98(4):499-503. doi: 10.1007/s12185-013-1434-5. Epub 2013 Sep 15. Int J Hematol. 2013. PMID: 24037455
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.
Yamamoto E, Fujisawa S, Hagihara M, Tanaka M, Fujimaki K, Kishimoto K, Hashimoto C, Itabashi M, Ishibashi D, Nakajima Y, Tachibana T, Kawasaki R, Kuwabara H, Koharazawa H, Yamazaki E, Tomita N, Sakai R, Fujita H, Kanamori H, Ishigatsubo Y. Yamamoto E, et al. Among authors: hagihara m. Cancer Sci. 2014 Jan;105(1):105-9. doi: 10.1111/cas.12321. Epub 2014 Jan 23. Cancer Sci. 2014. PMID: 24450386 Free PMC article.
The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients.
Ishii Y, Tomita N, Tateishi U, Ishiyama Y, Yamamoto E, Hattori Y, Hagihara M, Yamazaki E, Ishigatsubo Y. Ishii Y, et al. Among authors: hagihara m. Med Oncol. 2014 Mar;31(3):880. doi: 10.1007/s12032-014-0880-0. Epub 2014 Feb 7. Med Oncol. 2014. PMID: 24504845
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Tomita N, Kodama F, Tsuyama N, Sakata S, Takeuchi K, Ishibashi D, Koyama S, Ishii Y, Yamamoto W, Takasaki H, Hagihara M, Kuwabara H, Tanaka M, Hashimoto C, Yamazaki E, Koharazawa H, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y. Tomita N, et al. Among authors: hagihara m. Hematol Oncol. 2015 Mar;33(1):9-14. doi: 10.1002/hon.2136. Epub 2014 Feb 11. Hematol Oncol. 2015. PMID: 24519501 Clinical Trial.
Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Tomita N, Takasaki H, Ishiyama Y, Kishimoto K, Ishibashi D, Koyama S, Ishii Y, Takahashi H, Numata A, Watanabe R, Tachibana T, Ohshima R, Hagihara M, Hashimoto C, Takemura S, Taguchi J, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: hagihara m. Leuk Lymphoma. 2015 Mar;56(3):725-9. doi: 10.3109/10428194.2014.931953. Epub 2014 Aug 6. Leuk Lymphoma. 2015. PMID: 24913502
[T315I positive promyelocytic crisis of chronic myeloid leukemia].
Yamamoto E, Yamazaki E, Ishiyama Y, Koyama S, Ishii Y, Hattori Y, Nakajima Y, Tachibana T, Miyazaki T, Hagihara M, Tomita N, Ishigatsubo Y. Yamamoto E, et al. Among authors: hagihara m. Rinsho Ketsueki. 2014 Jun;55(6):692-6. Rinsho Ketsueki. 2014. PMID: 24975339 Review. Japanese.
Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation.
Numata A, Kajiyama R, Itabashi M, Ishii Y, Yamamoto W, Motohashi K, Matsumoto K, Hagihara M, Ishigatsubo Y, Fujisawa S. Numata A, et al. Among authors: hagihara m. Leuk Lymphoma. 2016;57(1):201-2. doi: 10.3109/10428194.2015.1037763. Epub 2015 May 12. Leuk Lymphoma. 2016. PMID: 25860242 No abstract available.
R-CHOP therapy alone for limited-stage follicular lymphoma.
Tomita N, Suzuki T, Ishiyama Y, Miyashita K, Takahashi H, Numata A, Ito S, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Yamazaki E, Taguchi J, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: hagihara m. Leuk Res. 2015 Jun;39(6):582-5. doi: 10.1016/j.leukres.2015.03.008. Epub 2015 Apr 6. Leuk Res. 2015. PMID: 25866096 Clinical Trial.
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy].
Koharazawa H, Watanabe R, Hattori Y, Numata A, Kawasaki R, Kuwabara H, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Taguchi J, Tomita N, Fujita H, Sakai R, Harano H, Ishigatsubo Y, Fujisawa S. Koharazawa H, et al. Among authors: hagihara m. Rinsho Ketsueki. 2015 Apr;56(4):392-9. doi: 10.11406/rinketsu.56.392. Rinsho Ketsueki. 2015. PMID: 25971269 Japanese.
Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Tachibana T, Tanaka M, Hagihara M, Kawasaki R, Yamazaki E, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: hagihara m. Int J Hematol. 2015 Oct;102(4):451-9. doi: 10.1007/s12185-015-1836-7. Epub 2015 Jul 15. Int J Hematol. 2015. PMID: 26173594
The bridge treatment selected at the decision for transplantation did not affect the outcomes in patients with MDS.
Kako S, Kanda Y, Kato J, Yamamoto W, Kato S, Onizuka M, Yokota A, Tatara R, Yokoyama H, Hagihara M, Usuki K, Gotoh M, Watanabe R, Kawai N, Saitoh T, Kanamori H, Takahashi S, Okamoto S. Kako S, et al. Among authors: hagihara m. Hematol Oncol. 2017 Sep;35(3):341-349. doi: 10.1002/hon.2276. Epub 2015 Dec 8. Hematol Oncol. 2017. PMID: 26643559
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.
Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y. Yamazaki E, et al. Among authors: hagihara m. Leuk Lymphoma. 2017 Jan;58(1):104-109. doi: 10.1080/10428194.2016.1190969. Epub 2016 Jun 7. Leuk Lymphoma. 2017. PMID: 27267543
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.
Tomita N, Suzuki T, Miyashita K, Yamamoto W, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Taguchi J, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Kawamoto K, Sone H, Takizawa J. Tomita N, et al. Among authors: hagihara m. Leuk Lymphoma. 2016 Dec;57(12):2763-2770. doi: 10.1080/10428194.2016.1195498. Epub 2016 Jun 20. Leuk Lymphoma. 2016. PMID: 27320054
Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis.
Yamamoto W, Andou T, Itabashi M, Koyama S, Ishii Y, Numata A, Motohashi K, Hagihara M, Matsumoto K, Fujisawa S. Yamamoto W, et al. Among authors: hagihara m. Intern Med. 2016;55(13):1721-7. doi: 10.2169/internalmedicine.55.6094. Epub 2016 Jul 1. Intern Med. 2016. PMID: 27374671 Free article.
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
Hagihara M, Iriyama N, Yoshida C, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Inokuchi K, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H. Hagihara M, et al. Oncol Rep. 2016 Nov;36(5):2976-2982. doi: 10.3892/or.2016.5110. Epub 2016 Sep 20. Oncol Rep. 2016. PMID: 27665844 Clinical Trial.
Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.
Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, Ogusa E, Koyama S, Numata A, Tomita N, Taguchi J, Fujisawa S, Kanamori H, Nakajima H. Tachibana T, et al. Among authors: hagihara m. Leuk Lymphoma. 2017 Jun;58(6):1403-1411. doi: 10.1080/10428194.2016.1243678. Epub 2016 Oct 14. Leuk Lymphoma. 2017. PMID: 27739916
Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Ando T, et al. Among authors: hagihara m. Int J Hematol. 2017 May;105(5):623-630. doi: 10.1007/s12185-017-2183-7. Epub 2017 Jan 21. Int J Hematol. 2017. PMID: 28110409
Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation.
Koyama S, Fujita H, Shimosato T, Kamijo A, Ishiyama Y, Yamamoto E, Ishii Y, Hattori Y, Hagihara M, Yamazaki E, Tomita N, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Koyama S, et al. Among authors: hagihara m. Probiotics Antimicrob Proteins. 2019 Mar;11(1):295-298. doi: 10.1007/s12602-018-9399-6. Probiotics Antimicrob Proteins. 2019. PMID: 29455334
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study.
Tachibana T, Andou T, Tanaka M, Ito S, Miyazaki T, Ishii Y, Ogusa E, Koharazawa H, Takahashi H, Motohashi K, Aoki J, Nakajima Y, Matsumoto K, Hagihara M, Hashimoto C, Taguchi J, Fujimaki K, Fujita H, Fujisawa S, Kanamori H, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Tachibana T, et al. Among authors: hagihara m. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):415-421. doi: 10.1016/j.clml.2018.03.009. Epub 2018 Mar 31. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29673622
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.
Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators. Kizaki M, et al. Int J Hematol. 2019 Apr;109(4):426-439. doi: 10.1007/s12185-019-02613-1. Epub 2019 Feb 14. Int J Hematol. 2019. PMID: 30762219 Clinical Trial.
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.
Ando T, Fujisawa S, Teshigawara H, Ogusa E, Ishii Y, Miyashita K, Motohashi K, Miyazaki T, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Yamazaki E, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Ando T, et al. Among authors: hagihara m. Int J Hematol. 2019 Jun;109(6):673-683. doi: 10.1007/s12185-019-02647-5. Epub 2019 Apr 8. Int J Hematol. 2019. PMID: 30963469
Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant.
Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Shimizu H, et al. Among authors: hagihara m. Bone Marrow Transplant. 2019 Dec;54(12):2020-2026. doi: 10.1038/s41409-019-0585-2. Epub 2019 Jun 11. Bone Marrow Transplant. 2019. PMID: 31186516
Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.
Matsumura A, Miyazaki T, Tachibana T, Ando T, Koyama M, Koyama S, Ishii Y, Takahashi H, Nakajima Y, Numata A, Yamamoto W, Motohashi K, Hagihara M, Matsumoto K, Fujisawa S, Nakajima H. Matsumura A, et al. Among authors: hagihara m. Turk J Haematol. 2020 Feb 20;37(1):20-29. doi: 10.4274/tjh.galenos.2019.2019.0139. Epub 2019 Aug 29. Turk J Haematol. 2020. PMID: 31464120 Free PMC article.
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S. Ohwada C, et al. Among authors: hagihara m. Biol Blood Marrow Transplant. 2020 Jan;26(1):162-170. doi: 10.1016/j.bbmt.2019.09.016. Epub 2019 Sep 16. Biol Blood Marrow Transplant. 2020. PMID: 31536824 Free article. Clinical Trial.
Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.
Tachibana T, Ishizaki T, Takahashi S, Najima Y, Kimura SI, Sakaida E, Onizuka M, Mori T, Fujisawa S, Fujiwara SI, Saito T, Hagihara M, Aotsuka N, Gotoh M, Usuki K, Tsukada N, Kanda J, Kanamori H, Kanda Y, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Tachibana T, et al. Among authors: hagihara m. Bone Marrow Transplant. 2020 Jul;55(7):1497-1501. doi: 10.1038/s41409-019-0689-8. Epub 2019 Sep 19. Bone Marrow Transplant. 2020. PMID: 31537900 No abstract available.
644 results